1. Home
  2. POAI vs NCI Comparison

POAI vs NCI Comparison

Compare POAI & NCI Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • POAI
  • NCI
  • Stock Information
  • Founded
  • POAI 2002
  • NCI 1992
  • Country
  • POAI United States
  • NCI Hong Kong
  • Employees
  • POAI N/A
  • NCI N/A
  • Industry
  • POAI Industrial Specialties
  • NCI
  • Sector
  • POAI Health Care
  • NCI
  • Exchange
  • POAI Nasdaq
  • NCI NYSE
  • Market Cap
  • POAI 8.9M
  • NCI 7.4M
  • IPO Year
  • POAI N/A
  • NCI 2024
  • Fundamental
  • Price
  • POAI $0.80
  • NCI $2.11
  • Analyst Decision
  • POAI Hold
  • NCI
  • Analyst Count
  • POAI 1
  • NCI 0
  • Target Price
  • POAI N/A
  • NCI N/A
  • AVG Volume (30 Days)
  • POAI 169.5K
  • NCI 162.8K
  • Earning Date
  • POAI 08-12-2025
  • NCI 07-29-2025
  • Dividend Yield
  • POAI N/A
  • NCI N/A
  • EPS Growth
  • POAI N/A
  • NCI 67.70
  • EPS
  • POAI N/A
  • NCI 0.26
  • Revenue
  • POAI $1,729,269.00
  • NCI $30,340,230.00
  • Revenue This Year
  • POAI $486.27
  • NCI N/A
  • Revenue Next Year
  • POAI $65.50
  • NCI N/A
  • P/E Ratio
  • POAI N/A
  • NCI $8.16
  • Revenue Growth
  • POAI 24.17
  • NCI 35.28
  • 52 Week Low
  • POAI $0.55
  • NCI $1.40
  • 52 Week High
  • POAI $3.06
  • NCI $9.00
  • Technical
  • Relative Strength Index (RSI)
  • POAI 37.42
  • NCI N/A
  • Support Level
  • POAI $0.78
  • NCI N/A
  • Resistance Level
  • POAI $0.82
  • NCI N/A
  • Average True Range (ATR)
  • POAI 0.05
  • NCI 0.00
  • MACD
  • POAI 0.00
  • NCI 0.00
  • Stochastic Oscillator
  • POAI 49.35
  • NCI 0.00

About POAI Predictive Oncology Inc.

Predictive Oncology Inc functions in the healthcare domain. The firm's reportable segments are Pittsburgh segment that provides services which include the application of AI using its proprietary biobank of 150,000+ tumor samples. It also creates proprietary 3D culture models used in drug development; Birmingham segment that provides contract services and research focused on solubility improvements, stability studies, and protein production; and Eagan segment that produces the FDA-cleared STREAMWAY System and associated products for automated medical fluid waste management and patient-to-drain medical fluid disposal. It derives maximum revenue from Eagan Segment.

About NCI NEO-CONCEPT INTL GRP HLDGS LTD

Neo-Concept International Group Holdings Ltd is a company that is a one-stop apparel solution services provider. The company offers a full suite of services in the apparel supply chain, including market trend analysis, product design and development, raw material sourcing, production and quality control, and logistics management serving customers located in the European and North American markets.

Share on Social Networks: